See more : ZIGExN Co., Ltd. (3679.T) Income Statement Analysis – Financial Results
Complete financial analysis of Healthpeak Properties, Inc. (PEAK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthpeak Properties, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- NCD Co., Ltd. (4783.T) Income Statement Analysis – Financial Results
- Synopsys, Inc. (0LBP.L) Income Statement Analysis – Financial Results
- WuHan Yangtze Communication Industry GroupCo.,Ltd (600345.SS) Income Statement Analysis – Financial Results
- Pool Corporation (POOL) Income Statement Analysis – Financial Results
- KISCO Holdings Corp. (001940.KS) Income Statement Analysis – Financial Results
Healthpeak Properties, Inc. (PEAK)
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.18B | 526.64M | 457.70M | 437.51M | 415.28M | 422.55M | 343.58M | 241.03M | 129.44M | 53.33M | 16.80M | 12.95M | 13.85M |
| Cost of Revenue | 902.66M | 171.10M | 137.41M | 128.20M | 124.82M | 122.62M | 97.04M | 66.00M | 31.03M | 10.15M | 4.65M | 4.76M | 4.95M |
| Gross Profit | 1.28B | 355.54M | 320.29M | 309.31M | 290.46M | 299.93M | 246.55M | 175.04M | 98.42M | 43.18M | 12.15M | 8.19M | 8.89M |
| Gross Profit Ratio | 58.61% | 67.51% | 69.98% | 70.70% | 69.94% | 70.98% | 71.76% | 72.62% | 76.03% | 80.96% | 72.32% | 63.25% | 64.23% |
| Research & Development | 0.00 | 0.25 | 0.07 | 0.13 | 0.14 | 0.57 | 0.22 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 95.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Selling & Marketing | 8.00M | 7.90M | 8.00M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 103.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Other Expenses | 0.00 | 189.64M | 157.87M | 149.59M | 146.44M | 158.39M | 125.16M | 86.59M | 45.47M | 16.73M | 5.11M | 4.15M | 4.59M |
| Operating Expenses | 103.13M | 229.85M | 195.63M | 183.35M | 179.54M | 187.21M | 148.12M | 104.99M | 60.38M | 28.17M | 8.80M | 5.46M | 5.84M |
| Cost & Expenses | 1.01B | 400.95M | 333.04M | 311.55M | 304.35M | 309.83M | 245.15M | 170.99M | 91.41M | 38.33M | 13.45M | 10.22M | 10.79M |
| Interest Income | 0.00 | 72.23M | 60.14M | 57.18M | 10.90M | 11.56M | 8.49M | 8.86M | 3.88M | 1.07M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 200.33M | 72.23M | 60.14M | 57.18M | 65.02M | 66.18M | 47.01M | 23.86M | 10.64M | 6.91M | 435.25M | 4.54M | 415.46M |
| Depreciation & Amortization | 749.90M | 1.71B | 1.58B | 1.47B | 951.11M | 1.41B | 1.46B | 1.41B | 45.47M | 16.73M | 5.11M | 4.43M | 4.78M |
| EBITDA | 1.19B | 314.54M | 280.96M | 1.13B | 257.34M | 989.69M | 926.97M | 1.29B | 1.13B | 1.16B | 1.71B | 1.51B | 1.25B |
| EBITDA Ratio | 54.54% | 59.73% | 61.39% | 62.69% | 61.97% | 64.19% | 65.13% | 65.03% | 64.59% | 59.69% | 60.44% | 55.27% | 69.32% |
| Operating Income | 1.18B | 124.90M | 123.09M | 124.70M | 110.90M | 112.73M | 98.43M | 70.05M | 38.04M | 15.01M | 1.41M | 1.56M | 1.62M |
| Operating Income Ratio | 53.88% | 23.72% | 26.89% | 28.50% | 26.70% | 26.68% | 28.65% | 29.06% | 29.38% | 28.14% | 8.41% | 12.07% | 11.68% |
| Total Other Income/Expenses | -860.27M | -585.65M | -894.39M | -533.07M | -130.62M | 121.75M | -148.23M | -905.82M | -1.07B | -882.22M | -423.23M | -432.06M | -542.92M |
| Income Before Tax | 314.94M | 110.04M | 86.78M | 68.49M | 77.19M | 58.32M | 39.77M | 31.52M | 12.74M | -4.42M | -2.64M | -2.85M | -3.33M |
| Income Before Tax Ratio | 14.44% | 20.89% | 18.96% | 15.65% | 18.59% | 13.80% | 11.58% | 13.08% | 9.84% | -8.28% | -15.69% | -22.04% | -24.01% |
| Income Tax Expense | -9.62M | 72.23M | 61.38M | 58.29M | 67.70M | 11.78M | 48.82M | 25.52M | 11.69M | 6.62M | 5.59M | 3.34M | 6.11M |
| Net Income | 306.01M | 37.80M | 25.40M | 10.20M | 9.49M | 56.23M | 38.15M | 29.98M | 11.79M | -4.04M | -2.24M | -1.66M | -3.06M |
| Net Income Ratio | 14.03% | 7.18% | 5.55% | 2.33% | 2.28% | 13.31% | 11.10% | 12.44% | 9.11% | -7.57% | -13.32% | -12.79% | -22.10% |
| EPS | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.31 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| EPS Diluted | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.30 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| Weighted Avg Shares Out | 547.01M | 538.81M | 538.93M | 204.24M | 185.77M | 470.55M | 163.12M | 138.51M | 79.88M | 36.30M | 14.15M | 11.73M | 11.73M |
| Weighted Avg Shares Out (Dil) | 547.28M | 539.15M | 539.24M | 211.15M | 191.63M | 475.39M | 168.23M | 143.25M | 84.32M | 36.30M | 14.15M | 11.73M | 11.73M |
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated lead-in data from the company's ongoing Phase 3...
7 Cheap Russell 2000 Stocks to Buy Now: May 2024
The rest of 2024 could be a breakout period for cheap Russell 2000 stocks. Thus far, the index posted a 3.6% gain since January, though it lags the S&P 500's 10% bump.
S&P Stocks To Trade In May
For this month, the cycle/relative strength concept is applied. First, the S&P 500 stocks are ranked from the best performer to the worst by calculating the expected return in that month.
Compound Your Wealth With These Undervalued Dividends
Planning for retirement requires a step-by-step approach and the power of compounding through dividend reinvestment and capital appreciation. Healthpeak Properties and Comcast are two undervalued picks with strong asset bases that offer potential for income and growth. Healthpeak Properties is...
The Top 3 REITs to Buy in April 2024
Research firm Nareit's prediction that 2024 will be a year that top REITs are “well-situated for outsized performance” hasn't yet come to fruition. Much of its predictive power rested on the assumption that the Fed would cut rates early in...
Juicy 5% Yields Are Now Rare — But They're Still Out There
Don't kick yourself if you didn't load up on investments returning 5% on your cash last year. They still can be found.
3 Stocks to Buy if the Fed Keeps Rates High for the Rest of 2024
“Higher for longer” may prove true as sticky inflation indicates the higher-rate environment might be here to stay. As interest rates stay steady, risk-averse investors gravitate towards short-term Treasuries for safety.
Healthpeak (PEAK) Wraps Up Merger With Physicians Realty Trust
Healthpeak (PEAK) closes its merger with Physicians Realty Trust, positioning it well to capitalize on the secular trends of the industry.
Healthpeak Properties to Present at the Citi 2024 Global Property CEO Conference and Publishes Updated Investor Presentation
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, its President and Chief Executive Officer, is scheduled to present at the Citi 2024 Global...
Healthpeak Properties Closes Merger with Physicians Realty Trust
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced that it has closed on the previously announced merger with Physicians Realty Trust. The combined company will operate under the name “Healthpeak Properties, Inc.” and is expected to begin trading under...
Source: https://incomestatements.info
Category: Stock Reports